HepQuant: A New Investigative Tool to Evaluate the Liver
What if liver-disease researchers and drug developers had a minimally-invasive, accurate and more convenient alternative to traditional methods of measuring liver function and levels of fibrosis and cirrhosis? A major hurdle to anti-fibrotic therapy development is the ability to measure drug efficacy. Clinical trials require invasive methods to assess the impact of drugs in development. Compared to traditional and other emerging liver tests, HepQuant approaches the problem of liver diagnostics from a completely different perspective.